# Cannabidiol in Patients With Heart Failure Failure in AHA/ACC Stages A-C

> **NCT03634189** · PHASE1 · UNKNOWN · sponsor: **Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud** · enrollment: 20 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Cannabidiol

## Key facts

- **NCT ID:** NCT03634189
- **Lead sponsor:** Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634189, "Cannabidiol in Patients With Heart Failure Failure in AHA/ACC Stages A-C". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03634189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*